“Novo Nordisk is owned by Novo Holdings A/S, which is owned by the Novo Nordisk Foundation. The Novo Nordisk Foundation is a charitable foundation with a dual mission:
Produce insulin and sell it at cost in Scandinavia
Export insulin elsewhere in Europe and around the world at market prices, and use the profits to fund diabetes research and development”